Table 4. HSV2-specific epitopes were predicted.
| Epitope | Protein | Accession | Prevalence |
|---|---|---|---|
| GGPEEFEGAGD | Envelope glycoprotein G | P13290 | 1 |
| PLYARTTPAKF | Tegument protein UL47 | P89467 | 1 |
| VDSQRLTPGGSVS | Tegument protein UL21 | P89444 | 1 |
| KARKKGTSAL | Envelope glycoprotein B | P08666 | 1 |
| TPLRYACVL | Tegument protein UL47 | P89467 | 1 |
| ANSPWAPVL | mRNA export factor | P28276 | 1 |
| RYSPLHN | Envelope glycoprotein B | P08666 | 1 |
| EAMLNDAR | Large tegument protein deneddylase | P89459 | 1 |
| QRLTPH | Large tegument protein deneddylase | P89459 | 1 |
| LRYTPAGEV | Envelope glycoprotein H | P89445 | 1 |
| RTPSMR | Major viral transcription factor ICP4 homolog | P90493 | 1 |
| LATNNA | Small capsomere-interacting protein | P89458 | 0.917 |
| LRTNNL | Ribonucleoside-diphosphate reductase small subunit | P69521 | 0.917 |
| PRTTPTPPQ | Envelope glycoprotein C | Q89730 | 0.833 |
| HRLYAVVA | Inner tegument protein | P89460 | 0.833 |
| PSTPAMLNLG | Ribonucleoside-diphosphate reductase large subunit | P89462 | 0.667 |
| VTKHTALCAR | Large tegument protein deneddylase | P89459 | 0.583 |
| TRDYAGL | Envelope glycoprotein I | P13291 | 0.583 |
| RLTVAQ | Envelope glycoprotein I | P13291 | 0.583 |
| RSLGIA | Protein UL20 | P89443 | 0.583 |
| IRDLARTFA | Thymidine kinase | P89446 | 0.5 |
| DITAKHRCL | Major capsid protein | P89442 | 0.5 |
| ETPAQPPRY | Capsid scaffolding protein | P89449 | 0.5 |
| VSGITPTQ | Tripartite terminase subunit 1 | P89451 | 0.5 |
| HEELYYGPVS | Tegument protein VP22 | P89468 | 0.417 |
| IQDLAYAIV | Ribonucleoside-diphosphate reductase large subunit | P89462 | 0.417 |
| GPAQRHTY | DNA polymerase catalytic subunit | P89453 | 0.417 |
| YFEEYAYS | Envelope glycoprotein B | P08666 | 0.417 |
| LDDFDL | Tegument protein VP16 | P68336 | 0.417 |
| AARLIDALYAEFLGG | Envelope glycoprotein H | P89445 | 0.333 |
A total of 30 epitopes were predicted that were 100% specific against HSV1.